EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 308 filers reported holding EXELIXIS INC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,074,000 | +31.5% | 45,226 | -4.7% | 0.04% | +14.3% |
Q1 2020 | $817,000 | +173.2% | 47,448 | +184.5% | 0.04% | +218.2% |
Q3 2019 | $299,000 | -36.8% | 16,675 | -24.6% | 0.01% | -31.2% |
Q2 2019 | $473,000 | -19.1% | 22,116 | -10.0% | 0.02% | -20.0% |
Q1 2019 | $585,000 | -27.9% | 24,578 | -35.1% | 0.02% | -35.5% |
Q2 2018 | $811,000 | – | 37,888 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |